Tiffany Richards provides an overview of the most common questions she hears from patients regarding daratumumab.
TOP - March 2022 Vol 15, No 2 published on March 16, 2022 in ASH, Lymphoma
TOP - March 2022 Vol 15, No 2 published on March 16, 2022 in ASH
Web Exclusives published on November 5, 2019 in Financial Toxicity, Head and Neck Cancer, Hematologic Cancers, In the News, Leukemia
Last modified: July 22, 2021